Skip to main contentSkip to navigation
Sirius Investors
Covetrus, Inc.

Covetrus, Inc.

CVET
NASDAQHealthcare

Covetrus, Inc. (CVET) Investment Research Dashboard

About Covetrus, Inc. (CVET) stock analysis

Get live CVET stock price $20.99, comprehensive Covetrus, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time CVET stock data and investment insights.

20.99
0.00%Today
Market Cap
0
Volume
5.30M
52W High
21.20
52W Low
13.39

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Covetrus, Inc. functions as a technology and services provider for the animal health sector. The company supplies a comprehensive range of animal health consumables, including its own branded and proprietary items, along with diverse equipment (small...

Company Information

CEO
Benjamin Wolin
Sector
Healthcare
Industry
Medical - Distribution
Employees
4035

Contact Information

Address
7 Custom House St
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Distribution

Investment Highlights

Strong presence in the Healthcare sector with established market position

Higher growth potential with elevated volatility (Beta: 1.51)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Covetrus, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for large-cap equities
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Covetrus, Inc.
  • Investors should consider how Covetrus, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis
0

P/E Ratio (TTM)

-69.97

Beta

1.51

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

73/100 ⭐⭐⭐⭐⭐

Overall
+0.6%
NYSE
+0.7%
NASDAQ
+0.4%
Sector1D1W1MP/EScore
Financial Services+1.9%+2.8%+4.0%19.2
98/100⭐⭐⭐⭐⭐
Communication Services+1.5%-0.5%+3.1%22.3
74/100⭐⭐⭐⭐⭐
Healthcare+0.6%+1.2%+1.5%24.0
73/100⭐⭐⭐⭐⭐
Basic Materials+0.9%+1.7%+0.2%25.3
66/100⭐⭐⭐⭐
Consumer Defensive-0.0%+2.0%+0.9%29.8
63/100⭐⭐⭐⭐
Real Estate+0.4%+0.9%-1.6%29.5
50/100⭐⭐⭐
Energy-1.7%-3.3%-3.7%19.2
39/100⭐⭐
Utilities-1.1%-0.0%-4.5%26.8
35/100⭐⭐
Industrials+0.7%+0.5%-9.8%30.0
21/100
Technology+0.9%-1.3%-6.9%40.9
18/100
Consumer Cyclical+0.3%-1.7%-6.0%42.8
14/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.